Literature DB >> 21843956

Surgical consideration of in situ prosthetic replacement for primary infected abdominal aortic aneurysms.

C-H Lai1, C-Y Luo, P-Y Lin, C-D Kan, R-S Chang, H-L Wu, Y-J Yang.   

Abstract

OBJECTIVES: To review our surgical experience of primary infected abdominal aortic aneurysms, with the aim of assessing the safety and durability of in situ prosthetic replacement.
DESIGN: Retrospective study in a university hospital.
MATERIALS AND METHODS: Thirty-four patients who underwent surgery for primary infected abdominal aortic aneurysms over the past 18 years were reviewed. Operative details and outcomes were recorded for analysis.
RESULTS: There were six suprarenal and 28 infrarenal infections. Salmonellae (18 patients) were the most common pathogens. Thirty patients underwent in situ prosthetic replacement, two underwent extra-anatomic bypass and two underwent endovascular repair. The surgical mortality for overall patients was 18%, and for patients reconstructed in situ, 17%. Among the 30 patients reconstructed in situ, four patients who underwent concomitant gastrointestinal procedures (e.g., repair of the duodenal defect) died. By contrast, 25 of 26 patients without gastrointestinal involvement survived surgery. After a median follow-up period of 58 months, two discharged patients who underwent in situ reconstruction died of late graft infection.
CONCLUSIONS: Our experience suggests that in situ prosthetic replacement can be performed safely with durable outcomes in the majority of patients with infected abdominal aortic aneurysms. Nevertheless, we advise caution when considering this technique with concomitant gastrointestinal procedures.
Copyright © 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21843956     DOI: 10.1016/j.ejvs.2011.07.005

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  4 in total

1.  Infected iliac artery aneurysm with aortocaval fistula.

Authors:  Nozomu Sasahashi; Mikihisa Hamazaki; Hidenori Asada; Tsuyoshi Kataoka; Kunio Hamanaka; Kei Nishiyama
Journal:  Acute Med Surg       Date:  2016-05-03

2.  Primary Infected Aortic Aneurysm: Clinical Presentation, Pathogen, and Outcome.

Authors:  Cheng-Hsin Lin; Ron-Bin Hsu
Journal:  Acta Cardiol Sin       Date:  2014-11       Impact factor: 2.672

3.  Mycotic aneurysms in the abdominal aorta and iliac arteries: CT-based grading and correlation with surgical outcomes.

Authors:  Chao-Han Lai; Ruey-Sheng Chang; Chwan-Yau Luo; Chung-Dann Kan; Pao-Yen Lin; Yu-Jen Yang
Journal:  World J Surg       Date:  2013-03       Impact factor: 3.352

4.  miR-183 and miR-141 in lesion tissues are potential risk factors for poor prognosis in patients with infected abdominal aortic aneurysm.

Authors:  Chunying Meng; Zeheng Guo; Dagang Li; Hanwei Li; Jun Zhou; Dingguo Wen; Bin Luo
Journal:  Exp Ther Med       Date:  2018-09-13       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.